ES2689193T3 - La hormona paratiroidea biológica activa no oxidada determina mortalidad en pacientes en hemodiálisis - Google Patents
La hormona paratiroidea biológica activa no oxidada determina mortalidad en pacientes en hemodiálisis Download PDFInfo
- Publication number
- ES2689193T3 ES2689193T3 ES13158401.3T ES13158401T ES2689193T3 ES 2689193 T3 ES2689193 T3 ES 2689193T3 ES 13158401 T ES13158401 T ES 13158401T ES 2689193 T3 ES2689193 T3 ES 2689193T3
- Authority
- ES
- Spain
- Prior art keywords
- pth
- oxidized
- peptides
- human pth
- ipth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/635—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13158401.3A EP2775306B1 (en) | 2013-03-08 | 2013-03-08 | Non-oxidized, biological active parathyroid hormone determines mortality in hemodialysis patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2689193T3 true ES2689193T3 (es) | 2018-11-08 |
Family
ID=47827083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13158401.3T Active ES2689193T3 (es) | 2013-03-08 | 2013-03-08 | La hormona paratiroidea biológica activa no oxidada determina mortalidad en pacientes en hemodiálisis |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10613101B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2775306B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6526577B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2904433A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2689193T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014135701A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2714565T3 (es) | 2014-02-20 | 2019-05-29 | Immundiagnostik Ag | Diagnóstico in vitro y pronóstico de nefropatía inducida por contraste (nic) en pacientes sometidos a angiografía coronaria |
| EP3499235A1 (en) | 2017-12-13 | 2019-06-19 | Immundiagnostik AG | Method of measuring auto-antibodies in bodily fluids |
| WO2019141791A1 (en) * | 2018-01-17 | 2019-07-25 | Immundiagnostik Ag | Biomarker predicting coronary artery disease |
| ES2984718T3 (es) | 2018-08-20 | 2024-10-30 | Immundiagnostik Ag | Composición de sorbente para el tratamiento preanalítico de muestras |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988006596A1 (en) | 1987-03-02 | 1988-09-07 | Bissendorf Peptide Gmbh | New cardiodilatin fragment, process for preparing same and use thereof |
| CA2040264A1 (en) | 1990-04-12 | 1991-10-13 | Tatsuhiko Kanmera | Parathyroid hormone antagonists |
| DE4434551A1 (de) | 1994-09-28 | 1996-04-04 | Forssmann Wolf Georg Prof Dr D | Peptide aus der Sequenz des hPTH (1-37) |
| US6689566B1 (en) | 1999-01-14 | 2004-02-10 | Scantibodies Laboratory, Inc. | Methods, kits, and antibodies for detecting parathyroid hormone |
| DE19961350A1 (de) | 1999-12-17 | 2001-06-21 | Immundiagnostik Ag | Verfahren zur Bestimmung der Parathormon-Aktivität in einer menschlichen Probe |
| DE10116552A1 (de) * | 2001-04-03 | 2002-10-10 | Abc Armbruster Biochemicals | Verfahren zur Bestimmung der wirksamen Parathormon-Aktivität in einer Probe |
| US20030082179A1 (en) | 2001-07-03 | 2003-05-01 | Hutchison James Scott | Parathyroid hormone antibodies and related methods |
| EP2631247A1 (en) * | 2012-02-22 | 2013-08-28 | Immundiagnostik AG | Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress |
-
2013
- 2013-03-08 ES ES13158401.3T patent/ES2689193T3/es active Active
- 2013-03-08 EP EP13158401.3A patent/EP2775306B1/en active Active
-
2014
- 2014-03-07 JP JP2015560717A patent/JP6526577B2/ja active Active
- 2014-03-07 US US14/773,619 patent/US10613101B2/en active Active
- 2014-03-07 CA CA2904433A patent/CA2904433A1/en not_active Abandoned
- 2014-03-07 WO PCT/EP2014/054508 patent/WO2014135701A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2775306A1 (en) | 2014-09-10 |
| JP2016512323A (ja) | 2016-04-25 |
| CA2904433A1 (en) | 2014-09-12 |
| WO2014135701A1 (en) | 2014-09-12 |
| JP6526577B2 (ja) | 2019-06-05 |
| EP2775306B1 (en) | 2018-06-27 |
| US10613101B2 (en) | 2020-04-07 |
| US20160025748A1 (en) | 2016-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ebeling et al. | Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases | |
| US9316651B2 (en) | Methods and compositions for biomarkers of fatigue | |
| ES2622361T3 (es) | Biomarcadores de enfermedad renal | |
| WO2013078122A1 (en) | Diabetes diagnosis through the detection of glycated proteins in urine | |
| ES2689193T3 (es) | La hormona paratiroidea biológica activa no oxidada determina mortalidad en pacientes en hemodiálisis | |
| ES2288718T3 (es) | Panel de multiples marcadores para la diabetes de tipo 1 y de tipo 2. | |
| ES2716300T3 (es) | Medios y métodos de medición de la hormona paratiroidea en pacientes que sufren de estrés oxidativo | |
| RU2015116674A (ru) | Способ диагностики или мониторинга почечной функции или диагностики почечной дисфункции | |
| Yamashita et al. | Serum osteocalcin levels are useful as a predictor of cardiovascular events in maintenance hemodialysis patients | |
| WO2007136614A2 (en) | Assays and methods for the diagnosis and progression of alzheimer's disease using a multi-analyte marker panel | |
| JP2025530718A (ja) | 抗タウｍｔｂｒ抗体、ならびにタウの切断された断片の検出方法およびその用途 | |
| KR102033776B1 (ko) | 타우 단백질의 발현수준을 측정하는 제제를 포함하는 알츠하이머 중증도 진단용 조성물 및 이를 이용한 알츠하이머 중증도의 진단방법 | |
| Uzun et al. | The effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels | |
| RU2019144031A (ru) | Способ диагностики или мониторинга функции почек или диагностики дисфункции почек | |
| JP2009537812A (ja) | ２型糖尿病プリフォームのバイオマーカー、及び２型糖尿病プリフォームの存在又は不在を検出する方法 | |
| US20140228296A1 (en) | Diagnosis, prognosis, and treatment of kidney disease | |
| JP2012510614A (ja) | オピオルフィン等の塩基性プロリンリッチ涙液遺伝子産物のバイオマーカーとしての使用 | |
| Lee et al. | Association between the ratio of insulin-like growth factor-I to insulin-like growth factor binding protein-3 and inflammation in incident automated peritoneal dialysis patients | |
| JP2021528476A (ja) | ハプトグロビン関連タンパク質と関係する組成物および方法 | |
| WO2012081433A1 (ja) | アミロイドβ神経障害バイオマーカー | |
| JP2021515249A (ja) | 自己血液ドーピングの検出のための方法 | |
| EP4490521A1 (en) | Diagnostic markers of parkinson's disease | |
| CN111630386A (zh) | 糖尿病并发症用标志物 | |
| CN116802500A (zh) | 用于治疗肾损伤和肾衰竭的方法和组合物 | |
| Dargiewicz et al. | High Molecular Complexes of Insulin-Like Growth Factor-I in Human Saliva |